MarketPeel
Insider Trading Intelligence
Pricing
…
RG

Robert J. Gould

FULC
SEE REMARKS · FULCRUM THERAPEUTICS, INC. · CIK 0001577034
FILING MIX · LIFETIME28%/72%
BUYS
15
SELLS
38
TOTAL VALUE
$6.97M
COMPANIES
1
ACTIVE SINCE
Jan 2020
HOLDINGS NOW
32,000
AVG SELL PX
$14.36
TRADE KIND
SHOWING 53 / 53
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
30 backtested trades · 8 horizons · 9 pending
Forward-return performance of every backtestable P/S trade by Robert J. Gould, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d30+76.67%-11.80%-1.08%-10.72%-7.97%-4.34
14d30+86.67%-17.08%-1.60%-15.48%-9.90%-5.33
30d30+83.33%-18.09%-1.83%-16.26%-11.96%-4.76
60d30+93.33%-29.92%+1.50%-31.42%-24.85%-8.36
90d30+93.33%-43.68%+2.43%-46.11%-62.18%-8.14
180d30(1 pending)+86.21%-26.66%+8.20%-34.86%-54.33%—
1y30(4 pending)+92.31%-48.85%+19.97%-68.81%-80.92%—
2y30(4 pending)+84.62%-46.50%+26.85%-73.35%-80.81%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
FULC · 32,000 shares · as of Jun 30, 2026
0144,516289,033433,549578,065202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 15 buys / 38 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
FULC
FULCRUM THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
32,000——32,000Jun 30, 2026Jul 2, 2026 ↗View →
FULC
FULCRUM THERAPEUTICS, INC.
SALE
15,000$10.72$160.9K454,864Feb 2, 2026Feb 4, 2026 ↗View →
FULC
FULCRUM THERAPEUTICS, INC.
SALE
15,000$11.87$178.1K469,864Jan 2, 2026Jan 6, 2026 ↗View →
FULC
FULCRUM THERAPEUTICS, INC.
SALE
15,000$10.87$163.1K469,864Jan 2, 2026Feb 4, 2026 ↗View →
FULC
FULCRUM THERAPEUTICS, INC.
SALE
15,000$11.03$165.5K484,864Nov 19, 2025Nov 21, 2025 ↗View →
FULC
FULCRUM THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
36,000——36,000Jun 26, 2025Jun 30, 2025 ↗View →
FULC
FULCRUM THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
30,000——30,000Jun 17, 2024Jun 18, 2024 ↗View →
FULC
FULCRUM THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
30,000——30,000Jun 27, 2023Jun 29, 2023 ↗View →
FULC
FULCRUM THERAPEUTICS, INC.
SALE
Interim President & CEO
6,766$15.00$101.5K499,864Jan 13, 2023Jan 13, 2023 ↗View →
FULC
FULCRUM THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
19,000——19,000Jun 27, 2022Jun 29, 2022 ↗View →
FULC
FULCRUM THERAPEUTICS, INC.
SALE
71,435$8.09$577.9K506,630Jun 7, 2022Jun 8, 2022 ↗View →
FULC
FULCRUM THERAPEUTICS, INC.
PURCHASE
71,435$7.84$560.1K578,065Jun 7, 2022Jun 8, 2022 ↗View →
FULC
FULCRUM THERAPEUTICS, INC.
SALE
71,435——86,523Jun 7, 2022Jun 8, 2022 ↗View →
FULC
FULCRUM THERAPEUTICS, INC.
SALE
24,382——157,958Jun 6, 2022Jun 6, 2022 ↗View →
FULC
FULCRUM THERAPEUTICS, INC.
SALE
24,382$8.10$197.6K506,630Jun 6, 2022Jun 6, 2022 ↗View →
FULC
FULCRUM THERAPEUTICS, INC.
PURCHASE
24,382$7.84$191.2K531,012Jun 6, 2022Jun 6, 2022 ↗View →
FULC
FULCRUM THERAPEUTICS, INC.
SALE
25,551——182,340Jun 3, 2022Jun 6, 2022 ↗View →
FULC
FULCRUM THERAPEUTICS, INC.
SALE
25,551$7.95$203.1K506,630Jun 3, 2022Jun 6, 2022 ↗View →
FULC
FULCRUM THERAPEUTICS, INC.
PURCHASE
25,551$7.84$200.3K532,181Jun 3, 2022Jun 6, 2022 ↗View →
FULC
FULCRUM THERAPEUTICS, INC.
SALE
16,689——207,891Jun 2, 2022Jun 6, 2022 ↗View →
FULC
FULCRUM THERAPEUTICS, INC.
SALE
16,689$7.92$132.2K506,630Jun 2, 2022Jun 6, 2022 ↗View →
FULC
FULCRUM THERAPEUTICS, INC.
PURCHASE
16,689$7.84$130.8K523,319Jun 2, 2022Jun 6, 2022 ↗View →
FULC
FULCRUM THERAPEUTICS, INC.
SALE
5,631$24.02$135.2K506,630Apr 7, 2022Apr 11, 2022 ↗View →
FULC
FULCRUM THERAPEUTICS, INC.
SALE
5,631——224,580Apr 7, 2022Apr 11, 2022 ↗View →
FULC
FULCRUM THERAPEUTICS, INC.
PURCHASE
5,631$7.84$44.1K512,261Apr 7, 2022Apr 11, 2022 ↗View →
FULC
FULCRUM THERAPEUTICS, INC.
SALE
52,552——230,211Apr 5, 2022Apr 5, 2022 ↗View →
FULC
FULCRUM THERAPEUTICS, INC.
SALE
52,552$24.26$1.27M506,630Apr 5, 2022Apr 5, 2022 ↗View →
FULC
FULCRUM THERAPEUTICS, INC.
PURCHASE
52,552$7.84$412.0K559,182Apr 5, 2022Apr 5, 2022 ↗View →
FULC
FULCRUM THERAPEUTICS, INC.
SALE
7,235——282,763Apr 4, 2022Apr 5, 2022 ↗View →
FULC
FULCRUM THERAPEUTICS, INC.
SALE
7,235$24.02$173.7K506,630Apr 4, 2022Apr 5, 2022 ↗View →
FULC
FULCRUM THERAPEUTICS, INC.
PURCHASE
7,235$7.84$56.7K513,865Apr 4, 2022Apr 5, 2022 ↗View →
FULC
FULCRUM THERAPEUTICS, INC.
SALE
34,464$24.03$828.2K506,630Apr 1, 2022Apr 5, 2022 ↗View →
FULC
FULCRUM THERAPEUTICS, INC.
SALE
34,464——289,998Apr 1, 2022Apr 5, 2022 ↗View →
FULC
FULCRUM THERAPEUTICS, INC.
PURCHASE
34,464$7.84$270.2K541,094Apr 1, 2022Apr 5, 2022 ↗View →
FULC
FULCRUM THERAPEUTICS, INC.
SALE
See Remarks
789$12.43$9.8K506,630Mar 16, 2021Mar 17, 2021 ↗View →
FULC
FULCRUM THERAPEUTICS, INC.
SALE
See Remarks
9,211$12.13$111.8K507,419Mar 15, 2021Mar 17, 2021 ↗View →
FULC
FULCRUM THERAPEUTICS, INC.
SALE
See Remarks
1,673$14.56$24.4K516,630Feb 16, 2021Feb 18, 2021 ↗View →
FULC
FULCRUM THERAPEUTICS, INC.
SALE
See Remarks
6,542$14.19$92.8K518,303Feb 16, 2021Feb 18, 2021 ↗View →
FULC
FULCRUM THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
269,390——269,390Feb 2, 2021Feb 4, 2021 ↗View →
FULC
FULCRUM THERAPEUTICS, INC.
SALE
See Remarks
10,000$12.08$120.8K524,845Jan 20, 2021Jan 22, 2021 ↗View →
FULC
FULCRUM THERAPEUTICS, INC.
SALE
See Remarks
2,500$20.00$50.0K534,845Jul 8, 2020Jul 9, 2020 ↗View →
FULC
FULCRUM THERAPEUTICS, INC.
SALE
See Remarks
2,500$20.80$52.0K537,345Jun 25, 2020Jun 26, 2020 ↗View →
FULC
FULCRUM THERAPEUTICS, INC.
SALE
See Remarks
156$20.00$3.1K539,845Jun 9, 2020Jun 10, 2020 ↗View →
FULC
FULCRUM THERAPEUTICS, INC.
SALE
See Remarks
3,433$20.17$69.3K540,001Jun 5, 2020Jun 9, 2020 ↗View →
FULC
FULCRUM THERAPEUTICS, INC.
SALE
See Remarks
1,300$20.04$26.1K543,434Jun 4, 2020Jun 5, 2020 ↗View →
FULC
FULCRUM THERAPEUTICS, INC.
SALE
See Remarks
1,500$20.13$30.2K544,734Jun 3, 2020Jun 5, 2020 ↗View →
FULC
FULCRUM THERAPEUTICS, INC.
SALE
See Remarks
2,797$20.00$55.9K546,234Jun 2, 2020Jun 3, 2020 ↗View →
FULC
FULCRUM THERAPEUTICS, INC.
SALE
See Remarks
5$20.00$100549,031Jun 1, 2020Jun 3, 2020 ↗View →
FULC
FULCRUM THERAPEUTICS, INC.
SALE
See Remarks
1,390$20.08$27.9K549,036May 29, 2020Jun 1, 2020 ↗View →
FULC
FULCRUM THERAPEUTICS, INC.
SALE
See Remarks
1,919$20.01$38.4K550,426May 28, 2020Jun 1, 2020 ↗View →
FULC
FULCRUM THERAPEUTICS, INC.
SALE
See Remarks
2,500$20.00$50.0K552,345May 26, 2020May 28, 2020 ↗View →
FULC
FULCRUM THERAPEUTICS, INC.
SALE
See Remarks
2,500$20.00$50.0K554,845Feb 19, 2020Feb 20, 2020 ↗View →
FULC
FULCRUM THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
200,000——200,000Jan 23, 2020Jan 27, 2020 ↗View →
Other insiders · FULC
Loading peer insiders…
About this filer
CIK 0001577034
ROLE
See Remarks
PRIMARY
FULC
COMPANIES
1
ACTIVE SINCE
Jan 2020
MARKETPEEL · /INSIDER/0001577034DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback